Criteria to Start VTE Prophylaxis in Hospitalized Adults
Initiate VTE prophylaxis in hospitalized medical patients only when they are at high risk for VTE, using individualized risk assessment rather than universal prophylaxis, and always weigh bleeding risk against thrombotic risk before prescribing.
Risk Assessment Framework
The decision to start VTE prophylaxis requires systematic risk stratification, though no single standardized risk assessment model is mandated by guidelines 1. The 2018 ASH guidelines emphasize that prophylaxis should be reserved for patients deemed at elevated risk, while the 2011 ACP guidelines explicitly oppose universal prophylaxis performance measures 1, 2.
Key Risk Factors That Should Trigger Consideration:
Patient-Related Factors:
- Active malignancy
- Prior VTE history
- Age >75 years
- Severe immobility or paralysis
- Obesity
- Thrombophilia
Illness-Related Factors:
- Acute medical illness requiring hospitalization
- Heart failure
- Respiratory failure
- Acute infection
- Inflammatory conditions
- Stroke (ischemic or hemorrhagic)
Quantitative Risk Threshold: Recent evidence suggests a VTE probability threshold of approximately 1% represents an appropriate cutoff for initiating prophylaxis based on cost-effectiveness analysis 3. This threshold corresponds to roughly 20-25% of hospitalized medical patients being classified as high-risk.
Specific Clinical Scenarios
When to START Prophylaxis:
Acutely ill medical patients with reduced mobility and additional risk factors should receive pharmacological prophylaxis for a minimum of 7 days 2. The NICE 2018 guidelines specify this applies to patients with:
- Acute infections
- Heart failure exacerbations
- Respiratory failure
- Inflammatory conditions
Critically ill patients should receive daily VTE and bleeding risk assessments, with prophylaxis initiated when bleeding risk is acceptable 2.
Stroke patients present a special case: use intermittent pneumatic compression for 30 days or until mobile if anticoagulation is contraindicated 2.
When NOT to START Prophylaxis:
Do not initiate prophylaxis in:
- Low-risk medical patients (strong recommendation) 1
- Chronically immobilized outpatients or nursing home residents 2
- Patients with acute coronary syndrome (generally) 2
- Outpatients with only minor provoking factors 2
- Palliative care patients in the last days of life 2
- Psychiatric inpatients at low risk 4
Contraindications and Bleeding Risk
Assess bleeding risk before initiating pharmacological prophylaxis. Contraindications include:
- Active bleeding
- Severe thrombocytopenia
- Recent intracranial hemorrhage
- High bleeding risk procedures
If pharmacological prophylaxis is contraindicated: Consider intermittent pneumatic compression in high-risk patients, though evidence is limited in medical patients 1. Do not use graduated compression stockings - they are ineffective and cause skin damage (strong recommendation against) 1.
Prophylaxis Selection
First-line pharmacological options (all Grade 1A):
- LMWH (preferred in most guidelines) 2
- Low-dose unfractionated heparin (UFH)
- Fondaparinux
Special populations:
- Renal impairment: Use adjusted doses of LMWH or UFH 2
- Psychiatric patients at high risk: Conditional recommendation for parenteral prophylaxis 4
Critical Pitfalls to Avoid
Over-prophylaxis in low-risk patients: Studies show 67-75% of low-risk patients receive unnecessary chemical prophylaxis, representing significant overtreatment 5. This increases bleeding risk without benefit.
Relying on clinical gestalt alone: Physician perception of VTE risk often does not correlate with calculated risk, leading to both under- and over-treatment 6, 5.
Using graduated compression stockings: These are ineffective and harmful - do not use them 1.
Universal prophylaxis protocols: Performance measures promoting universal prophylaxis are inappropriate and not evidence-based 1.
Ignoring bleeding risk: The highest-risk VTE patients are paradoxically less likely to receive prophylaxis due to bleeding concerns, but this should be a deliberate decision, not an oversight 6.
Practical Implementation
The most effective approach involves formal risk stratification at admission using either validated risk assessment models (like the Padua Prediction Score) or structured assessment of illness severity and risk factors 2, 7. Hospitals should develop formal VTE prevention strategies rather than leaving decisions entirely to individual judgment 7.
Duration: Continue prophylaxis for the duration of hospitalization or until the patient is fully mobile, with minimum 7 days for acutely ill medical patients 2.